GlassScriptPhysician profile
Khalil Anouti
NPI 1124434360
$30,964.21
in general payments reported to CMS, 2019-2025
23 companies · $5,369 in 2025
The $5,369 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $1,693 · 2021: $3,183 · 2022: $7,149 · 2023: $8,873 · 2024: $4,347 · 2025: $5,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,293 · Food and Beverage: $6,957 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,292.61 |
| Food and Beverage | $6,956.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,340.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,617.53 | 2020-2025 | Diamondback Coronary, Xience Skypoint, Optis |
| Medtronic, INC. | $2,952.14 | 2021-2025 | Corevalve Evolut R, Hawkone |
| Edwards Lifesciences Corporation | $2,894.61 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cardiovascular Systems INC. | $2,228.90 | 2021-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $2,064.26 | 2019-2025 | Rotablator Rotational Atherectomy System Console Kit, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $1,850.97 | 2021-2025 | Impella |
| W. L. Gore & Associates, INC. | $1,394.87 | 2021-2022 | |
| Medtronic Vascular, INC. | $1,224.75 | 2019-2020 | |
| Inari Medical, INC. | $510.34 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $322.64 | 2022-2025 | Igt Devices Systems Undivided, Elca |
| Pfizer INC. | $138.30 | 2019-2020 | |
| Penumbra, INC. | $121.37 | 2025 | Indigo System |
| Endotronix, INC. | $118.52 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Astrazeneca Pharmaceuticals LP | $116.64 | 2019-2020 | |
| Chiesi USA, INC. | $88.36 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $73.47 | 2025 | |
| Amgen INC. | $67.58 | 2023-2024 | Repatha |
| Livanova USA, INC. | $59.23 | 2023 | Protekduo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.06 | 2022-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $34.76 | 2019-2022 | |
| United Therapeutics Corporation | $19.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.08 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalil Anouti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.